glp 1 agonists mechanism of action GLP-1 and Anesthesia: Considerations and Cautions for CRNAs GLP-1 receptor agonists review and
Description
Short-chain fatty acids (SCFAs) produced by gut bacteria through activation of the G protein-coupled free fatty acid receptors FFAR2 (GPR43) and FFAR3 (GPR41) induce GLP-1 Secretion [159]
Supporting Data: Studies show that protein-rich meals can increase GLP-1 secretion by 25-40%, depending on the protein type

Compounded medications contain identical active ingredients and undergo quality testing, but cost significantly less because they bypass corporate supply chains and marketing expenses

Many reports showed that GLP-1 effects involve neural modulation and peripheral effects, which increase satiety, resting energy expenditure and lower plasma concentrations of free fatty acids [20]-[22]

Metformin was the most common oral glucose-lowering therapy used, totalling 43% of all patients who were prescribed adjunctive therapies
